Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for those with chronic disease who inject themselves. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with less discomfort and without the anxiety of handling needles. Using precise pressure technology, the injection is administered through the skin via a jet the size of a strand of hair, ensuring optimal comfort. Real time tracking and reporting sets a new standard for interactivity between the patient and care teams, monitoring adherence and potentially improving patient outcomes. Come join us on this exciting journey of redefining chronic patient care and comfort.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Phone: +1 617-500-4348
Total raised: $36M
Founded date: 2012
Investors 2
Date | Name | Website |
- | 5AM Ventur... | 5amventure... |
- | Takeda Ven... | takeda.com |
Funding Rounds 2
Date | Series | Amount | Investors |
20.10.2015 | Series B | $25M | - |
16.10.2014 | Series A | $11M | - |
Mentions in press and media 6
Date | Title | Description | Source |
11.03.2024 | Needle-Free Injection System Market is growing at a CAGR of ... | Needle-Free Injection System market The Exactitude Consultancy Needle-Free Injection System Market R... | einpresswi... |
17.03.2017 | Meet The Finalists of SXSW Interactive Innovation Awards | Entrepreneurs, techies, and anyone with an appetite for innovation began to crowd the halls as the S... | tech.co/ne... |
25.10.2015 | PORTAL INSTRUMENTS CLOSES A $25 MILLION SERIES B FINANCING T... | - | 5amventure... |
20.10.2015 | Portal Instruments Closes $25M Series B Financing | Portal Instruments, Inc., a Cambridge, MA-based clinical stage drug delivery device company, closed ... | finsmes.co... |
16.10.2014 | Portal Instruments Completes $11M Series A Financing | Portal Instruments, Inc., a Cambridge, Massachusetts-based developer of innovative drug delivery sys... | finsmes.co... |
15.10.2014 | Portal Instruments Completes $11M Series A | CAMBRIDGE, MA, Leader in the development of innovative drug delivery systems, announced today that... | vcnewsdail... |